Tumoral markers in liver cirrhosis and hepatocellular carcinoma [3];Marcadores tumorales en la cirrosis hepática y el carcinoma hepatocelular

Gastroenterologia y Hepatologia

Volumn 28, Issue 5, 2005, Pages 308-

  Gomez Rubio M ^a   De Cuenca Moron B ^a   Dominguez M ^b  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; TUMOR MARKER;

HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 21044451713     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13074070     Document Type: Letter

References (3)

1. Crespo Valadés E, Malmierca Corral M. CA 125 elevado en la hepatopatía crónica con ascitis. Gastroenterol Hepatol. 2004; 27:558.
2. De Cuenca B, Domínguez M, Gómez-Rubio M, Frías R, García J. Serum tumour markers performance in patients with liver cirrhosis (CI) and hepatocellular carcinoma (HCC). Digestion. 1998; 59 Suppl 3:368-9.
3. Gómez-Rubio M, Domínguez M, De Cuenca B, De la Morena EJ, García J. Serum CA 125: a sensitive marker diagnosing hepatocellular carcinoma (HCC). Digestion. 1998;59 Suppl 3:369.